| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/24/2002 | EP1224170A1 6-position substituted indoline, production and use thereof as a medicament |
| 07/24/2002 | EP1224168A1 Antifungal enediynes |
| 07/24/2002 | EP1224166A1 Method of producing n-(4,5-bis-methanesulfonyl-2-methyl-benzoyl)-guanidine, the hydrochloride thereof |
| 07/24/2002 | EP1224164A1 Hydroxamic acid derivative as inhibitor of the formation of soluble human cd23 |
| 07/24/2002 | EP1224163A1 Use of carbonylamino derivatives against cns disorders |
| 07/24/2002 | EP1224161A1 Nitroxy derivatives of (r) and (s)-carnitine |
| 07/24/2002 | EP1224160A1 Polymorphic forms of sertraline hydrochloride |
| 07/24/2002 | EP1224155A2 Novel bicyclic cannabinoid agonists for the cannabinoid receptor |
| 07/24/2002 | EP1224022A1 Naturally extracted and synthetic hypoglycemic or hypolipidemic compositions |
| 07/24/2002 | EP1223988A1 Antisense modulation of tumor necrosis factor alpha converting enzyme (tace) expression |
| 07/24/2002 | EP1223986A2 Hydrogels derived from chitosan and poly(ethylene glycol) |
| 07/24/2002 | EP1223985A2 Dialysis solution including polyglycol osmotic agent |
| 07/24/2002 | EP1223984A2 Compounds that associate on the intermolecular level and aggregate bodies that contain them |
| 07/24/2002 | EP1223983A2 Methods and compositions for predicting, diagnosing and treating lipodystrophy |
| 07/24/2002 | EP1223981A1 Use of a cd40:cd154 binding interruptor to treat immunological complications of the eye |
| 07/24/2002 | EP1223980A2 Use of csf-1 inhibitors |
| 07/24/2002 | EP1223974A2 Medicament in order to induce tolerance |
| 07/24/2002 | EP1223971A2 Compositions and methods for preventing and treating transplant rejection |
| 07/24/2002 | EP1223969A2 Combined use of a plasminogen activator and il-2 inhibitors for neuroprotection |
| 07/24/2002 | EP1223966A2 Use of gdnf for treating corneal defects |
| 07/24/2002 | EP1223965A2 Modulation of angiogenesis |
| 07/24/2002 | EP1223961A1 Trail: an inhibitor of autoimmune inflammation and cell cycle progression |
| 07/24/2002 | EP1223951A1 Method of preventing adhesions with absorbable polyoxaesters |
| 07/24/2002 | EP1223950A2 Ribozyme therapy for the treatment of proliferative skin and eye diseases |
| 07/24/2002 | EP1223949A1 Extended release formulations of erythromycin derivatives |
| 07/24/2002 | EP1223948A2 Method of inhibiting nf-kappa-b with heparin, for treating cardiovascular diseases and inflammations |
| 07/24/2002 | EP1223947A1 Targeted vectors |
| 07/24/2002 | EP1223945A1 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 07/24/2002 | EP1223944A1 Thrombopoietin mimetics |
| 07/24/2002 | EP1223943A2 Therapeutic use of an inhibitor or an antagonist of an abc protein in bone |
| 07/24/2002 | EP1223942A2 Agents for the enhanced oxygen delivery in mammals |
| 07/24/2002 | EP1223941A2 Therapeutic treatments comprising administratoin of certain steroids for blood cell deficiencies |
| 07/24/2002 | EP1223940A2 Treatment of osteoporosis |
| 07/24/2002 | EP1223939A1 Method of treating weight gain |
| 07/24/2002 | EP1223938A1 TREATMENT OF MOVEMENT DISORDERS BY ADMINISTRATION OF 5-HYDROXYTRYPTAMINE RECEPTOR/$g(a) 2? ADRENERGIC RECEPTOR ANTAGONIST COMPOSITIONS |
| 07/24/2002 | EP1223937A2 Gene necessary for striatal function, uses thereof, and compounds for modulating same |
| 07/24/2002 | EP1223936A1 Oral formulations for anti-tumor compounds |
| 07/24/2002 | EP1223935A1 Methods of use of fluoroquinolone compounds against bacteria |
| 07/24/2002 | EP1223934A2 Combination therapy including camptothecin |
| 07/24/2002 | EP1223933A2 5-membered heterocycle derivatives, production thereof and use thereof as medicaments |
| 07/24/2002 | EP1223932A1 Compounds and methods |
| 07/24/2002 | EP1223931A1 Treatment or prevention of hypotension and shock |
| 07/24/2002 | EP1223930A1 Treatment of dyskinesia |
| 07/24/2002 | EP1223929A1 Cannabimimetic indole derivatives |
| 07/24/2002 | EP1223928A2 Use of flavones, coumarins and related compounds to treat infections |
| 07/24/2002 | EP1223927A2 Use of retigabin for treating neuropathic pain |
| 07/24/2002 | EP1223926A2 6-methoxy-2-naphthylacetic acid prodrugs compositions for treating inflammation |
| 07/24/2002 | EP1223925A2 Use of a fatty acid derivative for the treatment of external secretion disorders |
| 07/24/2002 | EP1223924A2 Use of csaids in rhinovirus infection |
| 07/24/2002 | EP1223923A1 Method for protecting normal cells from cytotoxicity of chemotherapeutic agents |
| 07/24/2002 | EP1223922A2 6-methoxy-2-naphthylacetic acid prodrugs for treating inflammation |
| 07/24/2002 | EP1223921A2 Tissue factor antagonists and methods of use thereof |
| 07/24/2002 | EP1223918A1 Pharmaceutical compositions comprising a hmg coa reductase inhibitor |
| 07/24/2002 | EP1223916A2 Neutral-cationic lipid for nucleic acid and drug delivery |
| 07/24/2002 | EP1223915A1 Dry powder compositions having improved dispersivity |
| 07/24/2002 | EP1223914A2 Orally distintegrating composition comprising mirtazapine |
| 07/24/2002 | EP1223913A2 Use of aromatic polycyclic compounds as activators of ppars-type receptors in a cosmetic or pharmaceutical composition |
| 07/24/2002 | EP1223809A1 Methods of treating hair loss comprising administering indoline compound |
| 07/24/2002 | EP1185260A4 Ascorbic acid composition and method for treatment of aging or damaged skin |
| 07/24/2002 | EP1173148A4 Method of improving the aesthetic appearance of epithelia |
| 07/24/2002 | EP1146886B1 Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic composition |
| 07/24/2002 | EP1117356A4 Methods and apparatus for improved administration of fentanyl and sufentanil |
| 07/24/2002 | EP1102743B1 Amide derivatives which are useful as cytokine inhibitors |
| 07/24/2002 | EP1100767B1 Novel phenylethylamine derivatives, a method for the production thereof and their use as medicaments |
| 07/24/2002 | EP1056357B1 Calorically dense nutritional composition |
| 07/24/2002 | EP1035841B1 Method for producing solid dosing forms |
| 07/24/2002 | EP1022960B1 Composition for suppressing withdrawal symptoms and craving for alcohol in alcoholics and preventing the abuse of alcohol in healthy subjects |
| 07/24/2002 | EP0983268B1 Amidine derivatives as inhibitors of nitric oxide synthase |
| 07/24/2002 | EP0966473B1 Thiazolobenzoheterocycles, preparation and medicines containing same |
| 07/24/2002 | EP0946495B1 Phenyl acetamides as spla2 inhibitors |
| 07/24/2002 | EP0938316B1 Galenic composition containing opioid antagonists |
| 07/24/2002 | EP0936910B1 Intracoronary stents containing quinazolinone derivatives |
| 07/24/2002 | EP0922034B1 Tetrahydroquinoline derivatives as eaa antagonists |
| 07/24/2002 | EP0904110B1 Nitric oxide donors capable of reducing toxicity from drugs |
| 07/24/2002 | EP0900793B1 Cycloalkylaminomethylpyrrolidine derivatives |
| 07/24/2002 | EP0900218B1 Heterocyclic compounds |
| 07/24/2002 | EP0886647B1 Serine protease inhibitors |
| 07/24/2002 | EP0885230B1 Camptothecin derivatives and the use thereof as antitumor agents |
| 07/24/2002 | EP0874632B1 High-content famciclovir tablets |
| 07/24/2002 | EP0869778B1 Improved perfluorocarbons for biological gas exchange and method |
| 07/24/2002 | EP0820454B1 Anellated beta-carbolines |
| 07/24/2002 | EP0814804B1 Substituted benzopyrans |
| 07/24/2002 | EP0804431B1 GLYCOPROTEIN IIb/IIIa ANTAGONISTS |
| 07/24/2002 | EP0799044B1 Topical ophthalmic formulations containing olopatadine for treating allergic eye diseases |
| 07/24/2002 | EP0758886B1 Use of perfluorocarbons for assisting normal breathing in mammals having lung disorders |
| 07/24/2002 | EP0742011B1 Percutaneously absorbable preparation |
| 07/24/2002 | EP0741716B1 Delta 12,13 -iso-taxol analogs, antineoplastic use and pharmaceutical compositions containing them |
| 07/24/2002 | EP0739210B1 Compositions for local delivery of cytostatic agents |
| 07/24/2002 | EP0734383B1 Cyclic amide derivatives as neurokinin a antagonists |
| 07/24/2002 | EP0699192B1 Substituted oxazolyl compounds for the treatment of inflammation |
| 07/24/2002 | EP0693070B1 PYRIDO[2,3-b](1,4)BENZODIAZEPINONES AS M2 RECEPTOR LIGAND FOR THE TREATMENT OF NEUROLOGICAL DISORDERS |
| 07/24/2002 | EP0687184B1 Recombinant adenoviruses and use thereof in gene therapy for treating eye diseases |
| 07/24/2002 | EP0684945B1 Pyrazole- or isoxazole-substituted alkyl amide acat inhibitors |
| 07/24/2002 | CN1360631A Methods and compositions for preventing formation of aberrant RNA during transcription of plasmid sequence |
| 07/24/2002 | CN1360629A Induction of vascular endothelial growth factor (VEGF) by serine/threonine protein kinase AKT |
| 07/24/2002 | CN1360596A Humanized immunoglobulin reactive with B7 molecules and methods of treatment therewith |
| 07/24/2002 | CN1360592A Streptogramin derivs., production thereof and composition contg. same |
| 07/24/2002 | CN1360591A 3 alpha-hydroxy-3 beta-methoxymethyl-21-heterocycle substd. steroids with anesthetic activity |
| 07/24/2002 | CN1360590A Androgen glycosides and androgenic activity thereof |
| 07/24/2002 | CN1360589A Orally active androgens |